OWP_Logo_Primary.png
OWP Pharmaceuticals Announces Patent Application for the First-Ever Powder for Oral Liquid Formulation of Duloxetine Hydrochloride for the Treatment of Major Depressive and Generalized Anxiety Disorder
July 08, 2020 08:00 ET | OWP Pharmaceuticals
NAPERVILLE, Ill., July 08, 2020 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
OWP_Logo_Primary.png
OWP Pharmaceuticals Announces Pre-IND Acknowledgement and Patent Application for the First-Ever Liquid Oral Suspension Formulation of Quetiapine Fumarate for the Treatment of Schizophrenia and Bipolar Disorder
January 08, 2020 08:00 ET | OWP Pharmaceuticals
NAPERVILLE, Ill., Jan. 08, 2020 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
Honeybees emerging from a BVT hive
REPEAT - Bee Vectoring Technologies Files New Patent for Computer-Controlled Honeybee Hive Dispenser System
December 11, 2019 08:00 ET | Bee Vectoring Technologies International Inc.
MISSISSAUGA, Ontario and SACRAMENTO, Calif., Dec. 11, 2019 (GLOBE NEWSWIRE) -- Bee Vectoring Technologies International Inc. (the “Company” or “BVT”) (TSXV: BEE) (OTCQB: BEVVF) today announced that...
Honeybees emerging from a BVT hive
Bee Vectoring Technologies Files New Patent for Computer-Controlled Honeybee Hive Dispenser System
December 11, 2019 01:00 ET | Bee Vectoring Technologies International Inc.
MISSISSAUGA, Ontario and SACRAMENTO, Calif., Dec. 11, 2019 (GLOBE NEWSWIRE) -- Bee Vectoring Technologies International Inc. (the “Company” or “BVT”) (TSXV: BEE) (OTCQB: BEVVF) today announced that...
OWP_Logo_Primary.png
OWP Pharmaceuticals Announces a Second IND Approval and Patent Application: The First-Ever Liquid Oral Suspension Formulation of Lamotrigine for the Treatment of Epilepsy and Bipolar Disorder
December 03, 2019 08:00 ET | OWP Pharmaceuticals
NAPERVILLE, Ill., Dec. 03, 2019 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc., a privately-held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and...
2019 Nextechar_logo_on-white_color.jpg
NexTech Adds to its IP Portfolio Filing A Non-Provisional Patent Application for Augmented Reality in a Retail Environment
March 26, 2019 07:30 ET | NexTech AR Solutions
NEW YORK, NY and TORONTO, ON, March 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – NexTech AR Solutions (the “Company” or “NexTech”) (OTCQB: NEXCF) (CSE: NTAR) (FSE:N29) is pleased to announce that...
ibn_169.jpg
NetworkNewsAudio Covers New Patent Application of NeutriSci International Inc. (TXS-V:NU) (OTCQB:NRXCF)
March 05, 2018 08:30 ET | NetworkNewsWire
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company for business, today announces the audio version of a...
It's 2010: Do You Know Where Your New Ideas Will Come From This Year?
January 20, 2010 17:09 ET | Author Roger Maxwell
DALLAS, TX--(Marketwire - January 20, 2010) - Roger Maxwell can walk and talk today because of a patent application, and the curious thing is that the patent application that saved him wasn't even...
iLumen
iLumen Files Patent for Financial Data Gathering, Conversion and Analysis Technology
March 04, 2004 09:00 ET | iLumen Inc.
ATLANTA, March 4, 2004 (PRIMEZONE) -- iLumen Inc., a financial information and technology company headquartered in Atlanta, today announced the filing of the first in a series of patent applications...